Multinational Study of Acinetobacter Bloodstream Infection: Clinical Outcomes and Global Epidemiology-PITT Protocol

NCT00524290 — Completed, 100 participants, University of Pittsburgh

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  
RegistryNCT00524290
StatusCompleted
Study typeObservational
Enrollment100 (Actual)
SponsorUniversity of Pittsburgh (Other)
ConditionsAcinetobacter Infections
Datesstart 2009-04-01, primary completion 2017-12-01, completion 2017-12-01, first posted 2007-09-03, last updated 2018-06-14
Locations1 site in United States

Related Papers Related Patents Related Grants Related Experts
All trials for Acinetobacter Infections

-Summary

The objectives of this multinational study are to assess the clinical outcomes of patients with Acinetobacter bloodstream infection and to further assess the predictors of mortality in this patient population. We also aim to characterize the molecular epidemiology of this remarkable organism in an attempt to further understand its transmission dynamics on a global level and to determine whether increased pathogenicity is geographically dependent.

Expand all sections  ·  Collapse all

+Detailed description

Medical records will be reviewed and information collected to assess the clinical outcomes of patients with Acinetobacter bloodstream infection and to further assess the predictors of mortality in this patient population.

+Eligibility

Sex: All, ages: 18 Years to any

Inclusion Criteria:

* Patients with Acinetobacter infections

Exclusion Criteria:

* Those that do not meet entry criteria

+Locations (1)

FacilityCityCountryStatus
University of Pittsburgh Medical CenterPittsburgh, PennsylvaniaUnited States

+Investigators